(INT) Intellego Technologies - Ratings and Ratios
UV Indicator Patch, UV Dose Card, Skin Sun Monitor
INT EPS (Earnings per Share)
INT Revenue
Description: INT Intellego Technologies
Intellego Technologies AB is a Swedish company that specializes in manufacturing and selling colorimetric ultraviolet (UV) indicators. Their product portfolio includes the UVC Dosimeter, a photochromic indicator that changes color in response to accumulated UV-C irradiation, and SmartSun Bands, which help individuals monitor their sun exposure to prevent sunburn and skin damage. These products cater to various industries, including healthcare, hospitality, and retail.
To evaluate Intellego Technologies performance, we can examine key performance indicators (KPIs) such as revenue growth, market share, and customer acquisition costs. With a market capitalization of 3658.84M SEK and a return on equity (RoE) of 45.44%, the company demonstrates a strong financial position. The price-to-earnings (P/E) ratio of 28.41 suggests that the stock is moderately valued relative to its earnings. Additionally, the companys ability to generate revenue from diverse industries and its expanding product portfolio are positive indicators of its growth potential.
From a technical analysis perspective, Intellego Technologies stock has shown a strong upward trend, with the short-term (SMA20) and long-term (SMA200) moving averages indicating a significant increase in stock price over time. The average true range (ATR) of 7.90 (5.99%) suggests moderate volatility, which may be attractive to some investors. To further assess the stocks potential, we can examine other KPIs such as the relative strength index (RSI), Bollinger Bands, and trading volume to gauge market sentiment and potential price movements.
To make informed investment decisions, it is essential to analyze Intellego Technologies financial statements, industry trends, and competitive landscape. By examining the companys revenue streams, profit margins, and cash flow generation, we can better understand its financial health and growth prospects. Furthermore, assessing the competitive landscape and industry trends can help identify potential opportunities and challenges that may impact Intellego Technologies future performance.
INT Stock Overview
| Market Cap in USD | 582m |
| Sub-Industry | Electrical Components & Equipment |
| IPO / Inception |
INT Stock Ratings
| Growth Rating | 95.5% |
| Fundamental | 82.6% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 502% |
| Analyst Rating | - |
INT Dividends
Currently no dividends paidINT Growth Ratios
| Growth Correlation 3m | 95% |
| Growth Correlation 12m | 94.5% |
| Growth Correlation 5y | 85.9% |
| CAGR 5y | 142.19% |
| CAGR/Max DD 3y | 2.18 |
| CAGR/Mean DD 3y | 8.09 |
| Sharpe Ratio 12m | -0.05 |
| Alpha | 0.14 |
| Beta | 0.840 |
| Volatility | 146.00% |
| Current Volume | 2049.6k |
| Average Volume 20d | 472.1k |
| Stop Loss | 148.2 (-7%) |
| Signal | 1.23 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (229.8m TTM) > 0 and > 6% of Revenue (6% = 33.1m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 18.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 71.93% (prev 36.32%; Δ 35.61pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 87.1m <= Net Income 229.8m (YES >=105%, WARN >=100%) |
| Net Debt (-61.0m) to EBITDA (353.4m) ratio: -0.17 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.91 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (30.2m) change vs 12m ago 7.25% (target <= -2.0% for YES) |
| Gross Margin 82.87% (prev 75.92%; Δ 6.95pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 104.7% (prev 67.61%; Δ 37.08pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.98 (EBITDA TTM 353.4m / Interest Expense TTM 334.3m) >= 6 (WARN >= 3) |
Altman Z'' 11.02
| (A) 0.56 = (Total Current Assets 532.5m - Total Current Liabilities 136.2m) / Total Assets 707.9m |
| (B) 0.43 = Retained Earnings (Balance) 303.6m / Total Assets 707.9m |
| (C) 0.62 = EBIT TTM 328.2m / Avg Total Assets 526.3m |
| (D) 1.67 = Book Value of Equity 304.7m / Total Liabilities 182.2m |
| Total Rating: 11.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.59
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 0.63% = 0.31 |
| 3. FCF Margin 6.12% = 1.53 |
| 4. Debt/Equity 0.06 = 2.50 |
| 5. Debt/Ebitda 0.09 = 2.49 |
| 6. ROIC - WACC (= 61.43)% = 12.50 |
| 7. RoE 63.33% = 2.50 |
| 8. Rev. Trend 89.85% = 6.74 |
| 9. EPS Trend 70.26% = 3.51 |
What is the price of INT shares?
Over the past week, the price has changed by -22.24%, over one month by +8.58%, over three months by +100.00% and over the past year by +614.80%.
Is Intellego Technologies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INT is around 196.95 SEK . This means that INT is currently undervalued and has a potential upside of +23.56% (Margin of Safety).
Is INT a buy, sell or hold?
What are the forecasts/targets for the INT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 300 | 88.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 220.8 | 38.5% |
INT Fundamental Data Overview
Market Cap SEK = 5.43b (5.43b SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 100.3m SEK (Cash And Short Term Investments, last quarter)
P/E Trailing = 23.3598
P/S = 9.7949
P/B = 10.3272
Beta = 1.463
Revenue TTM = 551.0m SEK
EBIT TTM = 328.2m SEK
EBITDA TTM = 353.4m SEK
Long Term Debt = 16.5m SEK (from longTermDebt, last quarter)
Short Term Debt = 16.5m SEK (from shortTermDebt, last quarter)
Debt = 33.1m SEK (Calculated: Short Term 16.5m + Long Term 16.5m)
Net Debt = -61.0m SEK (from netDebt column, last quarter)
Enterprise Value = 5.36b SEK (5.43b + Debt 33.1m - CCE 100.3m)
Interest Coverage Ratio = 0.98 (Ebit TTM 328.2m / Interest Expense TTM 334.3m)
FCF Yield = 0.63% (FCF TTM 33.7m / Enterprise Value 5.36b)
FCF Margin = 6.12% (FCF TTM 33.7m / Revenue TTM 551.0m)
Net Margin = 41.71% (Net Income TTM 229.8m / Revenue TTM 551.0m)
Gross Margin = 82.87% ((Revenue TTM 551.0m - Cost of Revenue TTM 94.4m) / Revenue TTM)
Tobins Q-Ratio = 17.60 (Enterprise Value 5.36b / Book Value Of Equity 304.7m)
Interest Expense / Debt = 538.3% (Interest Expense 178.0m / Debt 33.1m)
Taxrate = 25.98% (24.0m / 92.4m)
NOPAT = 242.9m (EBIT 328.2m * (1 - 25.98%))
Current Ratio = 3.91 (Total Current Assets 532.5m / Total Current Liabilities 136.2m)
Debt / Equity = 0.06 (Debt 33.1m / last Quarter total Stockholder Equity 525.7m)
Debt / EBITDA = 0.09 (Net Debt -61.0m / EBITDA 353.4m)
Debt / FCF = 0.98 (Debt 33.1m / FCF TTM 33.7m)
Total Stockholder Equity = 362.9m (last 4 quarters mean)
RoA = 32.47% (Net Income 229.8m, Total Assets 707.9m )
RoE = 63.33% (Net Income TTM 229.8m / Total Stockholder Equity 362.9m)
RoCE = 86.51% (Ebit 328.2m / (Equity 362.9m + L.T.Debt 16.5m))
RoIC = 61.43% (NOPAT 242.9m / Invested Capital 395.5m)
WACC = unknown (E(5.43b)/V(5.46b) * Re(9.11%)) + (D(33.1m)/V(5.46b) * Rd(none%) * (1-Tc(0.26)))
Shares Correlation 3-Years: 84.85 | Cagr: 3.62%
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 75.14% ; FCFE base≈33.7m ; Y1≈35.1m ; Y5≈40.4m
Fair Price DCF = 19.07 (DCF Value 586.2m / Shares Outstanding 30.7m; 5y FCF grow 4.37% → 3.0% )
EPS Correlation: 70.26 | EPS CAGR: 159.8% | SUE: N/A | # QB: 0
Revenue Correlation: 89.85 | Revenue CAGR: 130.3%